Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2022.0713
Abstract: This randomized clinical trial assesses the efficacy and cost-effectiveness of liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone for postoperative recovery and pain management among patients undergoing knee replacement. read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "International journal of surgery"
DOI: 10.1016/j.ijsu.2017.08.569
Abstract: OBJECTIVE To illustrate the efficacy liposomal bupivacaine versus interscalene nerve block for pain management after total shoulder arthroplasty. METHODS A systematic search was performed in Medline, PubMed, Embase, ScienceDirect and the Cochrane Library. Data on… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of minimally invasive gynecology"
DOI: 10.1016/j.jmig.2018.11.005
Abstract: STUDY OBJECTIVE To study the effects of liposomal bupivacaine (LB) compared with bupivacaine hydrochloride with lidocaine on postoperative day 1 pain scores. DESIGN A randomized controlled trial (Canadian Task Force classification 1). SETTING An academic… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Minimally Invasive Gynecology"
DOI: 10.1016/j.jmig.2019.09.716
Abstract: Study Objective To determine if liposomal bupivacaine TAP blocks affected perioperative opioid requirements and self-reported pain scores. Design Retrospective cohort study. Setting Academic tertiary care hospital. Patients or Participants Women undergoing laparoscopic hysterectomy for uteri… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "World neurosurgery"
DOI: 10.1016/j.wneu.2020.06.049
Abstract: BACKGROUND Liposomal bupivacaine (LB) is FDA-approved for administration into surgical sites for postsurgical analgesia. The liposomal formulation allows for sustained effects up to 72 hours. METHODS A retrospective study assessed patients undergoing lumbar interbody surgery.… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Seminars in thoracic and cardiovascular surgery"
DOI: 10.1053/j.semtcvs.2017.06.004
Abstract: Liposomal bupivacaine is designed to allow drug diffusion for up to 96 hours following a single administration. Our study aimed to evaluate the safety of liposomal bupivacaine as an intercostal nerve block as part of… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2017.1314262
Abstract: Abstract Objective: To assess postsurgical clinical and economic outcomes of patients who received local infiltration containing liposomal bupivacaine versus traditional bupivacaine for pain management following total hip arthroplasty (THA). Methods: This retrospective study included two… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Interactive cardiovascular and thoracic surgery"
DOI: 10.1093/icvts/ivx044
Abstract: OBJECTIVES The purpose of this research is to compare liposomal bupivacaine and bupivacaine/epinephrine for intercostal blocks related to analgesic use and length of stay following video-assisted thoracoscopic wedge resection. METHODS A retrospective study of patients… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Anesthesiology"
DOI: 10.1097/aln.0000000000004111
Abstract: Background: The interscalene nerve block provides analgesia for shoulder surgery. To extend block duration, provide adequate analgesia, and minimize opioid consumption, the use of adjuvants such as dexamethasone as well as the application of perineural… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000001628
Abstract: The control of pain is a central aspect of the patient experience in dermatologic surgery. In fact, the recognition of the importance of pain management has led to a wider movement in all fields of… read more here.